欢迎访问《标记免疫分析与临床》官方网站!
血清AGR2、ESM-1水平对晚期NSCLC患者EGFR-TKI治疗后预后的预测价值
郭峰睿, 王慧, 易国震, 颜晶晶
The Prognostic Value of Serum AGR2 and ESM-1 Levels in Patients with Advanced NSCLC After EGFR-TKI Treatment
GUO Fengrui, WANG Hui, YI Guozhen, YAN Jingjing
标记免疫分析与临床 . 2023, (9): 1485 -1489 .  DOI: 10.11748/bjmy.issn.1006-1703.2023.09.010